학술논문
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
14320851